SUBSCRIBE
SUBSCRIBE

Sanofi (France)

NEWS
Sanofi Rumored to Announce Job Cuts in U.S. Before Feb. 9
Job Trends
Sanofi Rumored to Announce Job Cuts in U.S. Before Feb. 9
January 22, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Sanofi Deepens Cancer Push by Deals with MA Startup Warp Drive Bio and Innate Pharma Worth $1.2 Billion
January 11, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
After Months of Rumors, MannKind Corporation and Sanofi Terminate Afrezza Deal
January 5, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Sanofi Pays $20 Million Milestone and Redeems Priority Review Voucher for Zealand Pharma ’s LixiLan
December 23, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Sanofi Looks to Shake Things Up via $25 Billion Asset Swap with Boehringer Ingelheim
December 15, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Analysts Tune Their Crystal Balls to 2016 M&A Prospects, Including Johnson & Johnson, Amgen, Biogen, Sanofi and Others
December 11, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Sanofi Creeps Up On Biogen’s MS Market Share
December 1, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
AstraZeneca PLC Unafraid it May Have Given Sanofi a Potential Blockbuster in Drug Swap
November 24, 2015
 · 
2 min read
Policy
Sanofi Whistleblower Alleges Company Attorneys Destroyed Documents
November 23, 2015
 · 
3 min read
Load More
JOBS
IN THE PRESS
Job Trends
Fast-Growing Accord Healthcare to Bring 100 New Jobs to Ex-Sanofi Site
March 7, 2016
 · 
1 min read
Deals
Merus Completes Acquisition Of Surgestone, Provames, Tredemine And Speciafoldine Rights From Sanofi
March 7, 2016
 · 
2 min read
Business
JDRF And Sanofi Announce Expansion Of Their Joint Research Collaboration To Include Development Of Glucose Responsive Insulin Therapies For Treatment Of Insulin-Dependent Diabetes
February 25, 2016
 · 
5 min read
Deals
Merus Buys Four Products from Sanofi for €22.5 Million
February 23, 2016
 · 
5 min read
Policy
Zealand Pharma Announces That Sanofis NDA For The Fixed-Ratio Combination (Lixilan) Of Lixisenatide And Insulin Glargine For Type 2 Diabetes Has Been Accepted For Review By The FDA
February 22, 2016
 · 
2 min read
Policy
FDA Accepts Sanofi New Drug Application For Once-Daily Fixed-Ratio Combination Of Insulin Glargine And Lixisenatide
February 22, 2016
 · 
4 min read
Business
Sanofi Delivered 2015 Business EPS Up 8.5% On A Reported Basis And Stable At Constant Exchange Rates Consistent With Guidance
February 9, 2016
 · 
8 min read
Business
Sanofi - Full Year 2015 Results
February 9, 2016
 · 
1 min read
Job Trends
Sanofi Execs to Meet on Tuesday with Worker Reps to Discuss Restructuring, Possible Job Cuts
February 1, 2016
 · 
1 min read
Drug Development
Regeneron And Sanofi Announce Sarilumab Biologics License Application Accepted For Review By US FDA
January 8, 2016
 · 
8 min read
Load More